PacRay International Holdings Limited provided earnings guidance for the six months ended 30 June 2021. For the period, it is expected that the Group will record: an increase in revenue by approximately 54.16% to approximately HKD 54.47 million for the six months ended 30 June 2021, as compared with approximately HKD 35.33 million for the six months ended 30 June 2020; an increase in gross profit by approximately 14.73% to approximately HKD 13.40 million for the six months ended 30 June 2021, as compared with approximately HKD 11.68 million for the six months ended 30 June 2020; and a loss attributable to owners of the parent of HKD 10.86 million for the six months ended 30 June 2021, as compared with approximately HKD 1.19 million for the six months ended 30 June 2020.